Development of Low Cost Diagnostic and Monitoring Method for Diabetes Prevention

As per WHO, 346 million people have diabetes; 80% deaths occur in low-middle income countries. Currently, physicians cannot easily detect Insulin Resistance (IR), which precedes clinical signs of diabetes undetected for decades. TechnoDevelop will research towards low-cost IR diagnostics targeting advance monitoring and prevention programs along with education and training.